Major Scope

  •  Lung Cancer
  •  Colorectal Cancer
  •  Pancreatic Cancer
  •  Breast Cancer
  •  Prostate Cancer
  •  Liver Cancer
  •  Leukemia
  •  Bladder Cancer
  •  Kidney Cancer
  •  Endometrial Cancer
  •  Oncology Case Reports
  •  Radiation Therapy

Abstract

Citation: Clin Oncol. 2017;2(1):1278.DOI: 10.25107/2474-1663-v2-id1278

The Role of Electromagnetic Pollution in Cancer Promotion

Magda Havas

Environmental and Resource Studies, Trent School of the Environment, Trent University, Peterborough, Canada

*Correspondance to: Magda Havas 

 PDF  Full Text Review Article | Open Access

Abstract:

Exposure to non-ionizing electromagnetic frequencies (EMF) that include extremely low frequency electric and magnetic fields, intermediate frequencies commonly referred to as dirty electricity, and both radio frequency and microwave wave radiation has been increasing. Epidemiological studies document an increased risk of cancer incidence and cancer deaths associated with cell phone use, Wi-Fi exposure, as well as living near broadcast antennas, cell phone antennas and power lines. Electromagnetic pollution at levels well below international guidelines has been shown to cause cancers (in vivo studies) and several plausible mechanisms (in vitro studies) have been identified that include, but are not limited to oxidative stress, altered calcium flux, and increased membrane permeability. Time is long overdue for the World Health Organization and governing bodies to establish guidelines that truly protect public health. Also, time it is for the medical community to incorporate strategies to deal with the harmful effects of electromagnetic pollution, as part of their medical protocol, and to teach about this concept at medical schools since our exposure is likely to continue to increase.

Keywords:

Cite the Article:

Havas M. The Role of Electromagnetic Pollution in Cancer Promotion. Clin Oncol. 2017; 2: 1278.

Journal Basic Info

  • Impact Factor: 3.231**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
  • PubMed NLM ID: 101705590

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Enhanced Recovery after Surgery Protocol for Patients Undergoing Radical Cystectomy
 Abstract  PDF  Full Text
Immunohistochemistry Biomarkers in Bladder Cancer: The Old and the New Immunohistochemistry Markers in Bladder Cancer
 Abstract  PDF  Full Text
View More...